Literature DB >> 1853342

Severe hypoxia produced by concomitant intoxication with sublethal doses of carbon monoxide and cyanide.

S J Moore1, I K Ho, A S Hume.   

Abstract

It has long been known that a number of tissue hypoxicants are generated in the fire scenario. However, until recently few investigators have undertaken to correlate smoke inhalation deaths with the simultaneous exposure to histotoxic hypoxicants. Carbon monoxide and hydrogen cyanide are two histotoxic hypoxicants that are generated in nearly every fire. Prior studies performed in our laboratory have demonstrated that death can result from concomitant exposure to otherwise sublethal concentrations of carbon monoxide and cyanide. Since most smoke inhalation victims exhibit acid/base anomalies, we sought to investigate whether the death associated with simultaneous exposure to these two hypoxicants, at concentrations widely held to be nonlethal, could be explained by acid/base imbalances. Male ICR mice were exposed to 0.35% carbon monoxide immediately after having been injected ip with potassium cyanide solution, or were challenged with either agent alone. Animals challenged with cyanide or carbon monoxide alone demonstrated significant hypoxia. However, animals challenged with both agents demonstrated much greater hypoxia than could be explained by an additive effect alone. Controls demonstrated no alteration in acid/base homeostasis. Blood pH perturbations were found to be due to severe lactic acidosis coupled with inadequate respiratory compensation. Thus, it appears that the synergistic lethal effect of simultaneous administration of carbon monoxide and cyanide are related to a precipitous decrease in blood pH, the tissue hypoxia and its resulting complications.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1853342     DOI: 10.1016/0041-008x(91)90004-x

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

Review 1.  [Treatment strategies for acute smoke inhalation injury].

Authors:  D M Maybauer; D L Traber; P Radermacher; D N Herndon; M O Maybauer
Journal:  Anaesthesist       Date:  2006-09       Impact factor: 1.041

2.  Cobinamide is superior to other treatments in a mouse model of cyanide poisoning.

Authors:  Adriano Chan; Maheswari Balasubramanian; William Blackledge; Othman M Mohammad; Luis Alvarez; Gerry R Boss; Timothy D Bigby
Journal:  Clin Toxicol (Phila)       Date:  2010-08       Impact factor: 4.467

3.  Antagonism of nitric oxide toward the inhibition of cytochrome c oxidase by carbon monoxide and cyanide.

Authors:  Linda L Pearce; Elisenda Lopez Manzano; Sandra Martinez-Bosch; Jim Peterson
Journal:  Chem Res Toxicol       Date:  2008-11       Impact factor: 3.739

4.  Immediate health effects of an urban wildfire.

Authors:  D Shusterman; J Z Kaplan; C Canabarro
Journal:  West J Med       Date:  1993-02

Review 5.  Inhalation Injury: Pathophysiology, Diagnosis, and Treatment.

Authors:  Samuel W Jones; Felicia N Williams; Bruce A Cairns; Robert Cartotto
Journal:  Clin Plast Surg       Date:  2017-04-18       Impact factor: 2.017

Review 6.  Case Files of the University of Massachusetts Toxicology Fellowship: Does This Smoke Inhalation Victim Require Treatment with Cyanide Antidote?

Authors:  Eike Hamad; Kavita Babu; Vikhyat S Bebarta
Journal:  J Med Toxicol       Date:  2016-06

Review 7.  Smoke Inhalation Injury: Etiopathogenesis, Diagnosis, and Management.

Authors:  Kapil Gupta; Mayank Mehrotra; Parul Kumar; Anoop Raj Gogia; Arun Prasad; Joseph Arnold Fisher
Journal:  Indian J Crit Care Med       Date:  2018-03

Review 8.  Inhalation injury: epidemiology, pathology, treatment strategies.

Authors:  David J Dries; Frederick W Endorf
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-04-19       Impact factor: 2.953

9.  Oxygen regulation of breathing through an olfactory receptor activated by lactate.

Authors:  Andy J Chang; Fabian E Ortega; Johannes Riegler; Daniel V Madison; Mark A Krasnow
Journal:  Nature       Date:  2015-11-12       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.